Indications

How is anemia in beta (β) thalassemia (BT) treated?

Understanding the options available to help manage the symptoms can help prepare you to talk to your doctor.

Photo of a hypothetical patient with anemia in beta thalassemia (BT) sitting in a doctors office wearing a blue button down speaking to a doctor wearing a white lab coat and stethoscope.

Anemia is usually treated with red blood cell (RBC) transfusions

People with BT are either:

  • Transfusion dependent (TD): rely on transfusions
  • Non-transfusion dependent (NTD): only need transfusions at certain times

Are there other treatments for anemia in BT?

Another type of medicine for people with transfusion-dependent BT is an erythroid maturation agent (EMA), which helps RBCs to mature.

Learn more about REBLOZYL, the first and only EMA.

Talking to your doctor about anemia in BT

You know your body better than anyone. To ensure your healthcare team is aware of how you’re doing, talk openly about how you’re feeling. Share how you feel with your healthcare team so, together, you can make decisions that are best for you.

Here are some questions you can use to start the conversation:

Chat bubble with question mark

How do I know if my current anemia treatment is working as well as it should?

Chat bubble with question mark

What are my treatment options?

Chat bubble with question mark

What are the benefits and risks of these treatment options?

Photo of a hypothetical patient with anemia in beta thalassemia (BT) from behind, wearing a white top speaking to a doctor wearing a white lab coat and stethoscope.

Knowing your options and talking with your healthcare team can help you manage anemia.



swoosh

This website is intended for U.S. residents 18 years of age or older.

REBLOZYL® is a trademark of Celgene Corporation, a Bristol Myers Squibb company.

Access Support® and Your REBLOZYL Connection are trademarks of Bristol-Myers Squibb Company.

REBLOZYL® is licensed from Merck & Co. Inc., Rahway, NJ, USA and its affiliates.

© 2024 Bristol-Myers Squibb Company.

2007-US-2400432  11/24